ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: Class E basic helix-loop-helix protein 74; EC:2.3.1.48; NCoA-1; Nuclear receptor coactivator 1; Protein Hin-2; RIP160; Renal carcinoma antigen NY-REN-52; SRC-1; Steroid receptor coactivator 1; bHLHe74
Storage: 2-8C
Application: Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected NCOA1 in U-2 OS cells.Affinity Binding Assay: A representative lot of this antibody bound recombinant human NCOA1 protein with a KD of 6.9 x 10-7 in an affinity binding assay. Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany